Bio-Rad Laboratories Inc (BIO)
Net profit margin
Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net income (ttm) | US$ in thousands | -1,844,202 | -778,694 | -1,325,609 | -322,369 | -637,323 | -153,537 | -424,026 | -188,960 | -3,627,532 | -6,034,686 | -1,942,424 | -101,126 | 4,245,898 | 6,658,660 | 4,045,450 | 4,097,765 | 3,806,263 | 3,520,647 | 1,947,011 | 1,579,392 |
Revenue (ttm) | US$ in thousands | 2,566,525 | 2,580,209 | 2,562,604 | 2,605,238 | 2,671,262 | 2,720,366 | 2,769,042 | 2,779,031 | 2,802,249 | 2,804,730 | 2,870,979 | 2,895,811 | 2,922,545 | 2,979,615 | 2,879,829 | 2,700,778 | 2,545,626 | 2,380,215 | 2,293,585 | 2,329,324 |
Net profit margin | -71.86% | -30.18% | -51.73% | -12.37% | -23.86% | -5.64% | -15.31% | -6.80% | -129.45% | -215.16% | -67.66% | -3.49% | 145.28% | 223.47% | 140.48% | 151.73% | 149.52% | 147.91% | 84.89% | 67.80% |
December 31, 2024 calculation
Net profit margin = Net income (ttm) ÷ Revenue (ttm)
= $-1,844,202K ÷ $2,566,525K
= -71.86%
The net profit margin for Bio-Rad Laboratories Inc has shown a significant fluctuation over the past several quarters. Initially, the net profit margin was very healthy, ranging from 67.80% to 151.73% in the period from March 2020 to March 2022. However, starting from June 2022, the net profit margin turned negative and continued to decline sharply, reaching as low as -71.86% by December 2024.
This negative trend in the net profit margin indicates that the company's expenses and costs exceeded its revenue generation during these quarters. Such a decline in profitability could be attributed to various factors such as increased operating expenses, lower sales volumes, or pricing pressures in the market.
It is essential for Bio-Rad Laboratories Inc to closely monitor and address the underlying issues that are impacting its profitability to improve its financial performance and ensure long-term sustainability.
Peer comparison
Dec 31, 2024